Glutathione protects a human insulinoma cell line from tumor necrosis factor-alpha-mediated cytotoxicity

Int J Clin Lab Res. 1997;27(1):44-7. doi: 10.1007/BF02827241.

Abstract

It is postulated that glutathione acting as a free oxygen radical scavenger may protect beta-cells from cytokine-mediated cytotoxicity in insulin-dependent diabetes. In this study the effect of glutathione in preventing the cytotoxic damage mediated by tumor necrosis factor-a in vitro towards a human beta-cell line (CM insulinoma) was investigated. CM cells were exposed in vitro to tumor necrosis factor-alpha, tumor necrosis factor-alpha plus glutathione or glutathione alone at different concentrations. The resulting cytotoxicity was measured using a colorimetric assay. Glutathione significantly reduced the cytotoxicity mediated by tumor necrosis factor-alpha in a dose-dependent fashion (P < 0.001). These results suggest a protective effect of glutathione on beta-cell cytotoxicity induced by tumor necrosis factor-alpha and encourage the use of glutathione in trials aimed at reducing the beta-cell damage occurring in insulin-dependent diabetes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Survival / drug effects
  • Free Radical Scavengers / pharmacology*
  • Glutathione / pharmacology*
  • Humans
  • Insulinoma
  • Islets of Langerhans / drug effects*
  • Reactive Oxygen Species
  • Recombinant Proteins / pharmacology
  • Tumor Cells, Cultured
  • Tumor Necrosis Factor-alpha / pharmacology*

Substances

  • Free Radical Scavengers
  • Reactive Oxygen Species
  • Recombinant Proteins
  • Tumor Necrosis Factor-alpha
  • Glutathione